The incidence and mortality rates of acquired immunodeficiency syndrome (AIDS) have declined recently in the United States, since widespread use of potent antiretroviral therapy became standard treatment for persons infected with the human immunodeficiency virus (HIV) (1) . However, the incidence of HIV remains high in some populations, especially injection drug users (IDUs) and young ethnic-minority men who have sex with men (2-6). Some investigators have reported substantial decreases in the incidence of HIV among IDUs (7) (8) (9) (10) . Other studies have found continued high rates of risk behavior in recent years, especially among cocaine users and crack smokers who are not in treatment (11) .
Studies of the incidence of HIV infection among drugusing populations are particularly important. There is an increased recognition of the importance of injection drug use in maintaining HIV transmission at epidemic levels in many countries. This recognition has led to expansion of prevention programs in these populations, such as peer counseling to reduce risk behavior (12) , methadone maintenance (13) , and harm-reduction programs including needle and syringe exchange (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) .
Various investigators have estimated the effect of these prevention strategies on the incidence of HIV as well as on the frequency of high-risk injection behavior. Wiebel et al. found a decrease in HIV incidence from 8.4 to 2.4 per 100 person-years among IDUs who were not currently in a treat-ment program during a 4-year period related to peer-based risk-reduction services targeting social networks of drug users in community settings (12) . Moss et al. (24) in San Francisco, California, and Metzger et al. (13) in Philadelphia, Pennsylvania, documented a lower HIV incidence among drug users attending methadone maintenance programs than among those not currently in a treatment program. In their Syringe Exchange Evaluation and in the Vaccine Preparedness Initiative, Des Jarlais et al. found a lower HIV incidence among New York City IDUs who were using syringe exchange programs-1.58 and 1.38 per 100 person-years, respectively-compared with the incidence among nonusers of syringe exchange programs in the Vaccine Preparedness Initiative, for whom the HIV incidence was 5.26 per 100 person-years (7) . In contrast to these results, evaluation of the incidence of HIV among needle exchange program users in the Canadian provinces of Montreal (25) and Vancouver (26) found a higher HIV incidence among IDUs using needle exchange programs than among nonusers. However, this comparison is complicated by the fact that needle exchange program users had a higher HIV prevalence and more frequent high-risk injection behavior at baseline than did drug users not enrolled in needle exchange programs (26) .
Studies of the effect of harm-reduction programs in Amsterdam, the Netherlands, found reductions in HIV incidence during the early years of the program, which leveled off after the program had been operative for several years (20) . A recent study among IDUs in San Francisco found that high-risk sexual behavior made an important contribution to the incidence of HIV in these street-recruited populations (27) .
We followed a cohort of 1,532 HIV-negative IDUs in Baltimore, Maryland, who were recruited by street outreach between 1988 and 1989. An analysis of the 188 (12.3 percent) who seroconverted between enrollment and December 1992 found an overall incidence during this period of 3.80 per 100 person-years (28). The incidence was higher in women during the first 2 years of follow-up and then declined, but the rates were relatively stable among men. Younger participants had a higher incidence, and the relative incidence was 1.58 times higher in all drug users in the cohort during periods of active drug injection. We also evaluated sex differences in the risk factors for HIV seroconversion in this population. We found that the important risks for HIV infection in men were needle sharing and homosexual behavior; however, among women, sexual risks were more important (29, 30) .
In this paper, we report the temporal trends of HIV incidence and drug-related and sexual risk behaviors and their association with HIV incidence in this cohort of 1,532 IDUs in Baltimore between 1988 and 1998. The cohort of participants recruited at baseline was supplemented by an additional enrollment of 338 HIV-uninfected subjects in 1994. This large sample of drug users enrolled and followed semiannually in a city in which 54 percent of AIDS cases have occurred among drug users (Baltimore City HIV/AIDS Epidemiologic Profile, Maryland State AIDS Administration, June 30, 2001 ) enabled us to evaluate changes in incidence and risk behavior over time in this population. The data allowed us to assess the effects of behavior changes on HIV incidence among drug users during a period of the increasing importance of drug-using populations in the AIDS epidemic and more comprehensive public health programs to prevent HIV.
MATERIALS AND METHODS

Study design
A total of 2,960 persons who had injected illicit drugs in the past 10 years were screened between February 1988 and March 1989 for enrollment in a longitudinal study of the natural history of HIV/AIDS. Potential participants were recruited through extensive community outreach, as described previously (31) . Screening and follow-up were conducted at a university-affiliated, freestanding study clinic. All participants were 18 years of age or older, were free of AIDS at baseline, and agreed to be tested for HIV and receive their results with counseling. Only 15 percent of participants were in a drug treatment program when they enrolled in the study, although about half had been in drug treatment in the past. After providing informed consent, participants underwent an interviewer-administered questionnaire and blood specimen collection. The study protocol was reviewed and approved by the Committee on Human Research at the Johns Hopkins Bloomberg School of Public Health in Baltimore.
At the screening-enrollment visit, 713 (24.1 percent) of the subjects were HIV positive (28, 31) . These HIV-positive subjects, along with about 150 HIV-negative controls, were enrolled in a longitudinal study to evaluate the natural history of HIV infection in drug users. We invited the remaining HIV-negative subjects to return for follow-up in 6 months. A total of 1,532 HIV-negative participants returned for a follow-up visit and were invited to participate in a prospective study of HIV incidence and risk behavior. Repeat interviews and blood specimens were obtained at 6-month intervals. To replenish the cohort because of loss from the study population of subjects who had seroconverted to HIV (n = 217), had died (n = 261), or were lost to follow-up (about 10 percent per year), 338 additional persons meeting the eligibility criteria were enrolled in 1994.
Data on sociodemographic characteristics, drug use history and practices, and sexual behavior within the last 6 months were obtained at semiannual interviews. Subjects who seroconverted were identified by testing their blood for HIV antibodies by enzyme-linked immunosorbent assay at each visit. Specimens that were repeatedly reactive according to this assay were confirmed by Western immunoblot. All subjects received their HIV test results and were counseled by trained personnel.
Study population
Subjects who were included in this analysis were HIV seronegative at their enrollment in the study and returned for at least one follow-up visit. HIV seroconverters, for whom there was more than a 3-year interval between their last HIV- 
Statistical analysis
Person-time methods were used to calculate the HIV incidence density between February 1988 and December 1998 (32) . The date of seroconversion was considered to be the midpoint between the last negative and first positive HIV test. Incidence rates were calculated by using specific exposure variables of interest, for example, gender, age, injection behavior, and type of sexual activity. These behavioral data were obtained by interview; follow-up interviews referred to behavior during the previous 6 months. We obtained data on needle exchange program attendance from the Baltimore needle exchange program by using nonnominal linkage (e.g., by using a reverse identifier that included a subject's initials, date of birth, gender, and mother's maiden name). Because the Baltimore needle exchange program began in August 1994, variables pertaining to attendance prior to that date were coded as zero. Needle exchange program attendance was examined stratified by injection frequency, since we previously found attenders to inject more frequently than those who did not attend such programs (22) .
Poisson regression was used to evaluate the effect of various exposure variables on the risk of HIV infection. In these models, the dependent variable is the incidence of HIV, measured as the number of new seroconverters in a given time interval divided by the size of the population at risk. The log of the HIV incidence rate is assumed to be linearly associated with the risk factors, and the model parameters, after exponentiation, can be interpreted as relative incidence, which is similar to the relative risk. Factors measured at every visit were entered into the models as timedependent covariates. When subjects missed study visits, the exposures reported for the preceding semiannual visit were carried forward up to a maximum of 1 year, after which they were treated as missing.
To determine the independent contribution of covariates of interest, we used multivariate Poisson regression models. To account for temporal trends in HIV seroconversion, we included a variable that represented the calendar year. Goodness of fit was evaluated by calculating the deviance of the model from the saturated model; the likelihood ratio test was used to assess statistical significance. The independent contribution of each exposure variable, after adjustment for the effects of the other covariates, was expressed as the adjusted relative incidence rate, or rate ratio. We examined temporal changes in the association of risk factors with HIV incidence by examining the relative incidence for these factors early and late in the study.
RESULTS
Of the 1,846 participants, 1,447 (78.4 percent) were male and 1,705 (92.4 percent) were African American. The median age was 35 years (interquartile range (IQR), 30-40 years) and the median duration of injecting drugs was 14 years (IQR, 6-24 years) at enrollment. In the 6 months prior to enrollment, 95 percent of participants reported having injected drugs; about half injected daily. Of a total of 17,021 study visits prior to seroconversion, the median number of visits per person was 8 (IQR, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . The median interval between study visits was 6.5 months.
The study population was expanded in 1994 by recruiting 338 additional subjects. When these subjects were compared with the 1,536 participants recruited in 1988-1989, a higher proportion of the subjects recruited more recently were female ( (table 1) , which amounted to a decrease of 12 percent per year on average (95 percent CI : 7.5 percent, 14.9 percent, p < 0.001). Table 2 shows the association between sociodemographic characteristics and risk of HIV seroconversion. Over the 11-year study period, HIV incidence was similar among females and males (rate ratio = 1.04, 95 percent CI: 0.8, 1.4). However, the incidence was higher among females (5.54/ 100 person-years) than males (3.89/100 person-years) between 1988 and 1992 but lower from 1993 to 1998 (females, 1.56/100 person-years; males, 2.35/100 personyears; table 1). The incidence was higher among young participants and progressively decreased from 5.09 per 100 person-years in subjects under 30 years of age to 1.87 per 100 person-years in those over age 40 years at baseline (rate ratio for younger vs. older subjects = 2.72, 95 percent CI: 1.89, 3.92; table 2). Participants who had at least a high school education had a lower incidence than those who did not (rate ratio = 0.66, 95 percent CI: 0.52, 0.84). Subjects with a higher income and those who were married had a lower incidence that was of borderline significance (table 2) . A history of being homeless in the interval when seroconversion occurred was also of borderline significance (table 2) .
The relation between drug-use-related behaviors and HIV seroconversion is shown in table 3. Several drug-related behaviors were significantly associated with an increased risk of HIV infection, including injection of cocaine or multiple drugs, increased frequency of injection, sharing of injection paraphernalia (especially with more than one partner), and use of a shooting gallery (table 3) . Methadone maintenance in the past 6 months was associated with a significantly lower HIV incidence. Conversely, subjects who had a history of drug detoxification had a borderline higher HIV incidence. Use of crack cocaine and a history of incar-ceration were not associated with an increased incidence of infection. The incidence of HIV infection was slightly, but not significantly higher among subjects who attended needle exchange programs. However, after these programs opened in 1994, only about 14 percent of our study population attended during these 6-month intervals. Our data suggested that both sexual and drug use behavior contributed to HIV seroconversion in this cohort (table 4) . A self-reported sexually transmitted infection during the period immediately prior to HIV seroconversion, male homosexual activity, and sex with another IDU were associated with increased HIV incidence. However, having more than one heterosexual partner and trading sex for drugs or money were not significant risk factors for HIV. When we looked at the interaction between heterosexual sex and drug injection frequency, it appeared that heterosexual sex without drug injection conferred an elevated, but nonsignificant increased risk. However, the combination of "no sex" and high frequency of injection constituted the highest risk group, but this risk was not significantly different from that for the combination sex and drug injection categories.
The risk factors associated with HIV incidence in the univariate analysis were evaluated in multivariate models, which were adjusted for time to account for the overall temporal trend of decreasing infection rates (table 5) . Several factors remained significant in this analysis, including age, education, gender in the later period, men having sex with men, frequency of drug use (i.e., daily or more than daily vs. less often), shooting gallery attendance, cocaine use, and a sexually transmitted infection (table 5) . After adjustment for these variables, the decreasing incidence over time in the study remained significant; the average decline after adjustment was 7 percent per year (relative incidence = 0.93, 95 percent CI: 0.89, 0.97). analysis showed that all risk factors had a similar effect on the incidence of HIV infections in the early and later intervals except for women, who were at lower risk than men only during the late period. Several drug use and sexual variables that were significant in the univariate analysis were not significant when added to the multivariate model. We analyzed temporal trends in the incidence of HIV and the reported drug use and sexual risk behaviors in the cohort. Figure 1 shows the trends in HIV incidence for the entire cohort and the subset of participants who were enrolled in 1994; overall incidence per 100 person-years declined from 4.58 in 1988 and 5.03 in 1989 to 1.44 in 1997 and 1.29 in 1998, respectively. The decline in incidence was parallel and overlapped between 1995 and 1998 for the subjects who had enrolled in 1988-1989 in the original cohort and the replacement subjects who enrolled in 1994.
The temporal trends for several drug use behaviors are shown in figure 2 for the participants who were at risk of HIV infection. Notable trends include a decline in drug injection in the past 6 months from about 80 percent between 1988 and 1991 to 60-70 percent in 1996-1998 and a steady decline in less-than-daily injection from 30-35 percent in 1988-1991 to 20-25 percent in 1996-1998 ( figure 2, top) . However, the proportion of participants who reported continuing drug use daily or more often was stable between 44 and 50 percent until 1995 and then declined to less than 40 percent in 1998. The proportion of subjects who reported sharing injection equipment declined during the course of the study; sharing with one or more than one other drug user became markedly less frequent in recent years, as did injecting in a shooting gallery ( figure 2, bottom) .
Trends in the reported sexual behaviors found to be associated with incident HIV infection are depicted in figure 3 . Generally, sexual risk behavior changed less than reported drug use practices. Trading sex for drugs or money and having sex with an anonymous partner were reported by about 30 percent of the subjects throughout the duration of the study. Similarly, the proportion of subjects reporting sex with another drug user was stable. Having multiple sex partners was reported by over half of the study participants in the early years of the study and declined to about 40 percent in 1997 and 1998. About 5 percent of males reported recent homosexual activity throughout the study ( figure 3, top) . A recent history of a sexually transmitted disease was reported by about 5-10 percent of the participants throughout the course of the study (figure 3, bottom).
DISCUSSION
Our data indicate that the incidence of HIV infection declined in a large cohort of IDUs in Baltimore during the past decade. There are a number of possible reasons for this decreasing incidence. We and others (28, 30, (33) (34) (35) found a higher HIV incidence among younger IDUs and those who began injecting recently. In our population, the HIV incidence rate was inversely related to the age of the subjects at the time of study enrollment. Therefore, aging of the population alone could lead to a lower incidence over time. However, since the incidence among the population who enrolled in 1994 declined similarly to that for those participants who enrolled in 1988-1989, the incidence in recent years probably reflected a general trend of decreasing HIV incidence among IDUs in Baltimore during the past decade. Investigators in New York (7, 9) and other locations (10) (11) (12) 20) have also reported a decreased HIV incidence among drug users recently compared with earlier in the epidemic, accompanied by reported decreases in needle sharing. Our study participants, even those who continued to inject daily or more often, reported decreased needle sharing and less frequent attendance at shooting galleries. The declining incidence among the participants in our study was impressive, and the incidence was substantially lower than it was during the early years of the study. There are several obstacles to preventing HIV infection in injection-drug-using populations; however, compared with those whose risk of infection is from sexual exposure alone, it is increasingly evident that preventing HIV infection in IDUs is feasible and that populations of IDUs in several cities in the United States and Europe are experiencing a lower incidence of HIV than they were a decade ago (7, 9, 10, 12, 20) . One of the strengths of our study was our ability to track temporal trends in risk behavior and HIV incidence in a large population of highrisk IDUs over more than a decade.
Our data also indicate that several demographic, drug use, and sexual behavior variables were associated with HIV incidence in this cohort. The demographic variables that were protective were higher educational attainment, older age, and being a woman in the period after 1994. In addition, in the univariate analysis, a higher annual income, being married, and not being homeless were of borderline significance. Each of these variables was likely to be associated with increased social support and resources to avoid or reduce high-risk behavior. Younger drug users often are initiated into drug use by older users who are more likely to be infected (33) (34) (35) (36) (37) . Drug users who injected daily, used cocaine as well as heroin, or used shooting galleries were found to be at increased risk of HIV infection after we controlled for demographic characteristics, sexual behavior, and calendar time. Several cross-sectional and longitudinal analyses of HIV infection in different populations of drug users also have identified the importance of some of these drug-using behaviors (7, 24, (37) (38) (39) (40) (41) . It is biologically plausible, and therefore not surprising, that these drug-using behaviors, which are correlated with increased needle sharing, are important risk factors for HIV infection.
In the univariate analysis, enrollment in a methadone maintenance program was associated with a significantly lower risk of HIV infection. However, many of the subjects in our cohort injected cocaine as well as heroin, so this behavior constrained the greater effectiveness of methadone maintenance for preventing HIV infection (42) . Our participants were enrolled in a methadone maintenance program for only about 15 percent of the person-years during this study. Nevertheless, either enrollment in a methadone maintenance program or attendance at a needle exchange program may provide some protection against HIV infection; these programs enable participants to be referred to a range of preventive and health care services, and there is a direct effect of methadone on opiate use and of syringe exchange programs on needle sharing (43) (44) (45) .
Our data suggested that sexual behaviors also increased the risk of HIV infection in our population (30) . However, there was an interaction between sexual and drug-using behavior; active drug users stratified by their frequency of injection (i.e., daily or more often than daily vs. less than daily) had a higher incidence of HIV when they were not sexually active. Although the reason for this interaction is unknown, it is possible that sexually active IDUs might use injection equipment that has been shared by fewer other drug users.
Sexual behavior variables that were associated with HIV incidence were male same-sex contact, history of a sexually transmitted disease, and sex with another IDU. In a previous analysis of the data, female IDUs were found to have a higher HIV incidence in the early years of the study; however, by 1992, the incidence declined to that found among males (28) . It is possible that the lower incidence among females during the later years of this study reflects the higher incidence among the most susceptible female participants early in the study. One strategy to infer the role of the reported reduction in risk behaviors, especially drugrelated behaviors, in the declining HIV incidence would be to compare the overall estimate of the time trend, a 12 percent decline per year, with the adjusted decline of 7 percent per year in the final model. This comparison would suggest that the reported reduction in risk behaviors only partially explains the declining rate of HIV infection in this cohort. There are several potential limitations to our study. Because our population was a sample of convenience recruited from drug users in Baltimore, we cannot be sure how representative the population is. Although our followup rates were quite high for a drug-using population, the data could have been influenced by losses to follow-up. Persons who did not return for follow-up were younger and were more likely to be homeless; these characteristics are associated with higher incidence rates. On the other hand, subjects who returned for follow-up were more likely to have reported more frequent injection and needle sharing at enrollment; both of these behaviors are associated with increased HIV incidence. Therefore, it is difficult to estimate whether the true incidence in our study population was likely to be higher or lower than the rate we observed.
The reduction in HIV incidence, as well as high-risk behavior, among drug users in Baltimore in recent years is a very encouraging finding of our research. These trends probably reflect, in part, the response to a concerted public health effort to prevent HIV infection among drug users and the response to the risk of acquiring HIV by drug-using populations. In particular, reductions in the frequency of needle sharing, especially with more than one person, and overall decreases in the frequency of drug use may have been responsible for the declining HIV incidence we found in this population. It is unlikely that increased use of highly active antiretroviral therapy by drug users in Baltimore played an important role in reducing the incidence of HIV, since only 14 percent of drug users had used this therapy as of July 1997, and 49 percent had not received any antiretroviral therapy by that time (46, 47) .
The high prevalence of HIV infection among drug users and the substantial numbers of drug users in Baltimore and other metropolitan areas in the northeastern United States, coupled with the continued occurrence of new HIV infections, indicate the need for expanded prevention strategies in populations of drug users. It is essential that preventive efforts continue and increase, because the current incidence of new infections remains unacceptably high. Furthermore, the incidence could very well increase in the future in the absence of a continued and concerted public health effort, as seems to have occurred recently in some populations of men who have sex with men (48) (49) (50) (51) (52) .
